685 related articles for article (PubMed ID: 16474078)
1. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological aspects of Strongyloides stercoralis infection in Okinawa, Japan.
Arakaki T; Kohakura M; Asato R; Ikeshiro T; Nakamura S; Iwanaga M
J Trop Med Hyg; 1992 Jun; 95(3):210-3. PubMed ID: 1597879
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
5. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
6. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
Hayashi J; Kishihara Y; Yoshimura E; Furusyo N; Yamaji K; Kawakami Y; Murakami H; Kashiwagi S
Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
[TBL] [Abstract][Full Text] [Related]
7. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
8. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
Einsiedel L; Fernandes L
Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
[TBL] [Abstract][Full Text] [Related]
9. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
10. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
[TBL] [Abstract][Full Text] [Related]
11. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
12. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
13. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
Arakaki T; Asato R; Ikeshiro T; Sakiyama K; Iwanaga M
Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843
[TBL] [Abstract][Full Text] [Related]
14. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies).
Courouble G; Rouet F; Herrmann-Storck C; Nicolas M; Candolfi E; Deloumeaux J; Carme B
West Indian Med J; 2004 Jan; 53(1):3-6. PubMed ID: 15114885
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in general inhabitants in non-adult T-cell leukemia (ATL)-endemic Hokkaido, Japan.
Kwon KW; Yano M; Sekiguchi S; Iwanaga M; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T
In Vivo; 1994; 8(6):1011-4. PubMed ID: 7772728
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of human T cell lymphotropic virus type 1 in patients attending a Brazilian dermatology clinic.
Nobre V; Guedes AC; Proietti FA; Martins ML; Nassif G; Serufo JC; Lambertucci JR;
Intervirology; 2007; 50(4):316-8. PubMed ID: 17622792
[TBL] [Abstract][Full Text] [Related]
18. Age-related prevalence of Strongyloides stercoralis infection in Okinawa, Japan.
Arakaki T; Iwanaga M; Asato R; Ikeshiro T
Trop Geogr Med; 1992 Oct; 44(4):299-303. PubMed ID: 1295137
[TBL] [Abstract][Full Text] [Related]
19. Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan.
Tanaka T; Hirata T; Parrott G; Higashiarakawa M; Kinjo T; Kinjo T; Hokama A; Fujita J
Am J Trop Med Hyg; 2016 Feb; 94(2):365-370. PubMed ID: 26621566
[TBL] [Abstract][Full Text] [Related]
20. Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
Dixon AC; Yanagihara ET; Kwock DW; Nakamura JM
West J Med; 1989 Oct; 151(4):410-3. PubMed ID: 2588581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
